KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
AcquisitionsAmortizatization of IntangiblesAmortizatization of IntangiblesAsset Writedowns and ImpairmentAsset Writedowns and ImpairmentCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Free Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Supernus Pharmaceuticals (SUPN) Deferred Taxes (2016 - 2026)

Supernus Pharmaceuticals has reported Deferred Taxes over the past 10 years, most recently at $19.0 million for Q4 2025.

  • Quarterly Deferred Taxes rose 26493.06% to $19.0 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $5.2 million through Dec 2025, up 125.85% year-over-year, with the annual reading at $5.2 million for FY2025, 125.85% up from the prior year.
  • Deferred Taxes was $19.0 million for Q4 2025 at Supernus Pharmaceuticals, up from -$2.6 million in the prior quarter.
  • Over five years, Deferred Taxes peaked at $19.0 million in Q4 2025 and troughed at -$13.0 million in Q1 2022.
  • The 5-year median for Deferred Taxes is -$4.3 million (2021), against an average of -$3.6 million.
  • Year-over-year, Deferred Taxes crashed 1160.23% in 2024 and then soared 26493.06% in 2025.
  • A 5-year view of Deferred Taxes shows it stood at -$4.5 million in 2021, then tumbled by 71.87% to -$7.8 million in 2022, then tumbled by 34.78% to -$10.5 million in 2023, then skyrocketed by 99.31% to -$72000.0 in 2024, then soared by 26493.06% to $19.0 million in 2025.
  • Per Business Quant, the three most recent readings for SUPN's Deferred Taxes are $19.0 million (Q4 2025), -$2.6 million (Q3 2025), and -$7.2 million (Q2 2025).